KOLOREKTUM.CZ | COLORECTAL CANCER SCREENING [ISSN 1804-0888]
česky | english | site map


NOP

PARTNERS AND EXPERT GUARANTORS
Partners and expert guarantors: MZ ČR, ČGS, SVL, SPL ČR, ČGPS, ČOS, VIZE
Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University
PROJECT SUPPORT
Project support: Roche, Ipsen, Orion Diagnostica, OnkoMaják

Cancer incidence continues to rise: 1 in 5 men, 1 in 6 women

In 2018, an estimated 18.1 million new cases cancer will be diagnosed globally, and 9.6 million will die from the disease, according to the latest report from the International Agency for Research on Cancer (IARC) [1].


One in 5 men and one in 6 women worldwide will develop cancer during their lifetime, and one in 8 men and one in 11 women will die from cancer.

Cancer incidence and mortality are rapidly growing worldwide, the report notes.

"The increasing cancer burden is due to several factors, including population growth and ageing as well as the changing prevalence of certain causes of cancer linked to social and economic development," the IARC commented in a statement. "This is particularly true in rapidly growing economies, where a shift is observed from cancers related to poverty and infections to cancers associated with lifestyles more typical of industrialized countries."

Read the whole article at medscape.com

Epidemiology of colorectal cancer in the Czech Republic and worldwide

Recent statistics have indicated that the burden of colorectal cancer in the Czech Republic is above the global average, and this applies particularly to Czech men. Czech colorectal cancer incidence rates (Fig. 1) in men rank 19th worldwide and 14th in Europe, while women’s rates rank 28th–29th worldwide and 18th–19th in Europe. From the global perspective, colorectal cancer incidence rates (Fig. 1) and mortality rates (Fig. 2) have continuously been highest in Central and West European countries. Among European countries in 2018, Hungary, Slovakia and Norway had the highest incidence rates of colorectal cancer; the Czech Republic ranked 15th. Analyses of other epidemiological indicators are available in the article Epidemiology of colorectal cancer: international comparison.

Figure 1: International comparison of colorectal cancer incidence rates. ASR(W) – age-standardized world incidence rate per 100,000 population. Left to right: both sexes, men, women. Source: GLOBOCAN 2018 [1].
Figure 2: International comparison of colorectal cancer mortality rates. ASR(W) – age-standardized world mortality rate per 100,000 population. Left to right: both sexes, men, women. Source: GLOBOCAN 2018 [1].

Reference

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 2018. doi: 10.3322/caac.21492.

 

Keywords: cancer incidence, International Agency for Research on Cancer (IARC), GLOBOCAN 2018, lung cancer, breast cancer, colorectal cancer, prostate cancer, liver cancer

5.12.2018 medscape.com, IBA FM MU


Back